Condition
Tinea Cruris clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Tinea Cruris clinical trials that are recruiting, at sites in 2 countries (most in Egypt (1), Pakistan (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
Dermatophyte antifungal susceptibility in Faisalabad: terbinafine and itraconazole MICs
This study tests how common skin fungus infections in Faisalabad respond to terbinafine and itraconazole by measuring the lowest drug levels that stop growth in patient samples.
-
MMR vaccine injections into lesions for stubborn ringworm of the body and groin (tinea corporis and cruris)
This pilot will test whether injecting the MMR vaccine into affected skin can help people ages 10–60 with tinea corporis or cruris that hasn't responded to standard antifungal treatments.
Related topics
Quick answers
How many Tinea Cruris clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Egypt (1 trial), Pakistan (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.